RMD Q2 2022 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q2 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$895M+11.9% YoY

Gross Profit

$504M56.4% margin

Operating Income

$249M27.8% margin

Net Income

$202M22.5% margin

EPS (Diluted)

$1.37

QoQ Revenue Growth

-1.0%

Cash Flow

Operating Cash Flow

$220M

Free Cash Flow

$180M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$4.7B

Total Liabilities

$1.6B

Stockholders' Equity

$3.1B

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$895M	$800M	+11.9%
Gross Profit	$504M	$462M	+9.0%
Operating Income	$249M	$222M	+12.2%
Net Income	$202M	$180M	+12.4%

Revenue Segments

Sleep And Respiratory

$796M89%

Software As Service

$99M11%

Geographic Segments

Us Canada And Latin America

$586M65%

Combined Europe Asia And Other Markets

$309M35%